The authors evaluated long-term outcome in 40 patients with myelodysplastic syndrome or acute myeloid leukemia, transplanted from related or unrelated donors following conditioning with targeted busulfan, fludarabine, and thymoglobulin.
[Bone Marrow Transplantation]
7992332
{7992332:BBBBBBBB}
apa
50
1
168783
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
